Morgan Stanley’s iShares Health Innovation Active ETF BMED Stock Holding History
Bought
Maintained
Sold
Other funds holding BMED
Morgan Stanley's BMED Position: Q2 2024 in Review
Morgan Stanley sold out of iShares Health Innovation Active ETF (BMED) in Q2 2024, closing a stake of 710 shares — an estimated $18.7K sold.
Morgan Stanley first reported a position in BMED in Q1 2024 and held it in 1 quarter. The position peaked at $18.7K in Q1 2024. 5 funds tracked by Wall St. Rank hold BMED as of Q2 2024.
- Morgan Stanley reported no remaining iShares Health Innovation Active ETF position as of Q2 2024 after selling out during the quarter.
- Morgan Stanley sold 710 iShares Health Innovation Active ETF shares in Q2 2024, an estimated $18.7K.
- Morgan Stanley first reported a position in iShares Health Innovation Active ETF in Q1 2024 and held it in 1 quarter.
- Morgan Stanley's iShares Health Innovation Active ETF position peaked at $18.7K in Q1 2024.
- 5 funds tracked by Wall St. Rank held iShares Health Innovation Active ETF as of Q2 2024.
Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.